NEWS & INSIGHT
Find out what’s new in the pharmaceutical and biotech industries and how it affects you.
Contact firstname.lastname@example.org for more information.
Shire agrees to Takeda’s $62B buyout bid.Read Press Release
Teva to close several of its manufacturing sites and cut 25% of its workforce as part of its campaign to cut annual spending by $3B.Read More
MSD Animal Health, known as Merck Animal Health in the United States and Canada, today announced plans to purchase a new manufacturing facility in Krems an der Donau, Austria with the intention to expand its global vaccine manufacturing capacity. The facility, currently owned by Shire plc., was built in 2002 and will add to the company’s impressive global manufacturing capabilities.Read Press Release
Nitto Denko Avecia Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio), both located in Irvine, CA. Irvine is a leading analytical development services provider and Avrio is a premier cGMP parenteral contract manufacturing organization. Avecia will consolidate both businesses into the newly established company, Nitto Avecia Pharma Services.Read Press Release